Skip to main content

Advances in Cancer Medicine: Our Momentum of Discovery

 

Featured Content |Content Library

What is Immunopeptidomics? News

What is Immunopeptidomics?

Adjuvant Ribociclib for Early-Stage Hormone Receptor-Positive Breast Cancer - Updated in 2025 Document

Adjuvant Ribociclib for Early-Stage Hormone Receptor-Positive Breast Cancer - Updated in 2025

2025 American Society of Clinical Oncology (ASCO) Symposium

2025 American Society of Clinical Oncology (ASCO)

New Study Unveils Potential Therapeutic Pathways for Aggressive Pediatric Brain Tumor News

New Study Unveils Potential Therapeutic Pathways for Aggressive Pediatric Brain Tumor

Contraception in Patients With a History of Breast Cancer  Document

Contraception in Patients With a History of Breast Cancer 

CDK4/6 Inhibitors after Progression on CDK4/6 Inhibitor in Patients With Hormone Receptor-Positive/HER2-negative Advanced Breast Cancer Document

CDK4/6 Inhibitors after Progression on CDK4/6 Inhibitor in Patients With Hormone Receptor-Positive/HER2-negative Advanced Breast Cancer

Education/CME

Receive Dana-Farber's
e-newsletter, Momentum,
to learn of advances in cancer research and care, current clinical trials, and upcoming CME programs.